Literature DB >> 7473524

ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'?

J G Cleland1.   

Abstract

Currently there is concern that ACE inhibitors are not being utilised to their maximum potential for the prevention or treatment of heart failure. Underutilisation of ACE inhibitors has been attributed to a lack of appropriate medical education of physicians. However, an alternative explanation is that the trials have failed to answer important questions about how ACE inhibitors should be used in heart failure and that physician prescribing is appropriate to the current state of knowledge. The lack of evidence of benefit in patients with heart failure over the age of 75 years and of any substantial controlled trial in patients with apparent heart failure and well-preserved left ventricular systolic function, a common finding in elderly patients, may be common reasons why ACE inhibitors appear to be prescribed infrequently for heart failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473524

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

Review 1.  Contemporary management of heart failure in clinical practice.

Authors:  J G F Cleland
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.

Authors:  M Lough; J Cleland; J Langan; A Cowley; A Wade
Journal:  BMJ       Date:  1998-11-14

Review 3.  Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients?

Authors:  F D Hobbs
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis.

Authors:  Diane M Richardson; Kevin T Bain; James J Diamond; Karen D Novielli; Seina P Lee; Neil I Goldfarb
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 4.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.